207 related articles for article (PubMed ID: 37323125)
1. A CBT-based mobile intervention as an adjunct treatment for adolescents with symptoms of depression: a virtual randomized controlled feasibility trial.
Kulikov VN; Crosthwaite PC; Hall SA; Flannery JE; Strauss GS; Vierra EM; Koepsell XL; Lake JI; Padmanabhan A
Front Digit Health; 2023; 5():1062471. PubMed ID: 37323125
[TBL] [Abstract][Full Text] [Related]
2. Preliminary Efficacy of a Digital Intervention for Adolescent Depression: Randomized Controlled Trial.
Peake E; Miller I; Flannery J; Chen L; Lake J; Padmanabhan A
J Med Internet Res; 2024 Feb; 26():e48467. PubMed ID: 38324367
[TBL] [Abstract][Full Text] [Related]
3. Self-Guided Digital Intervention for Depression in Adolescents: Feasibility and Preliminary Efficacy Study.
Miller I; Peake E; Strauss G; Vierra E; Koepsell X; Shalchi B; Padmanabhan A; Lake J
JMIR Form Res; 2023 Nov; 7():e43260. PubMed ID: 37991839
[TBL] [Abstract][Full Text] [Related]
4. Chatbot-Delivered Cognitive Behavioral Therapy in Adolescents With Depression and Anxiety During the COVID-19 Pandemic: Feasibility and Acceptability Study.
Nicol G; Wang R; Graham S; Dodd S; Garbutt J
JMIR Form Res; 2022 Nov; 6(11):e40242. PubMed ID: 36413390
[TBL] [Abstract][Full Text] [Related]
5. Assessing the Efficacy and Safety of a Digital Therapeutic for Symptoms of Depression in Adolescents: Protocol for a Randomized Controlled Trial.
Furman DJ; Hall SA; Avina C; Kulikov VN; Lake JI; Padmanabhan A
JMIR Res Protoc; 2023 Nov; 12():e48740. PubMed ID: 37971800
[TBL] [Abstract][Full Text] [Related]
6. Feasibility, Acceptability, and Preliminary Efficacy of a Smartphone App-Led Cognitive Behavioral Therapy for Depression Under Therapist Supervision: Open Trial.
Wilhelm S; Bernstein EE; Bentley KH; Snorrason I; Hoeppner SS; Klare D; Greenberg JL; Weingarden H; McCoy TH; Harrison O
JMIR Ment Health; 2024 Apr; 11():e53998. PubMed ID: 38592771
[TBL] [Abstract][Full Text] [Related]
7. A Relational Agent Intervention for Adolescents Seeking Mental Health Treatment: Protocol for a Randomized Controlled Trial.
Chiauzzi E; Robinson A; Martin K; Petersen C; Wells N; Williams A; Gleason MM
JMIR Res Protoc; 2023 Mar; 12():e44940. PubMed ID: 36867455
[TBL] [Abstract][Full Text] [Related]
8. Brief App-Based Cognitive Behavioral Therapy for Anxiety Symptoms in Psychiatric Inpatients: Feasibility Randomized Controlled Trial.
Sharma G; Schlosser L; Jones BDM; Blumberger DM; Gratzer D; Husain MO; Mulsant BH; Rappaport L; Stergiopoulos V; Husain MI
JMIR Form Res; 2022 Nov; 6(11):e38460. PubMed ID: 36322113
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Using Mobile Apps to Assess and Treat Depression in Hispanic and Latino Populations: Fully Remote Randomized Clinical Trial.
Pratap A; Renn BN; Volponi J; Mooney SD; Gazzaley A; Arean PA; Anguera JA
J Med Internet Res; 2018 Aug; 20(8):e10130. PubMed ID: 30093372
[TBL] [Abstract][Full Text] [Related]
11. Use of a Mobile App to Augment Psychotherapy in a Community Psychiatric Clinic: Feasibility and Fidelity Trial.
Adam A; Jain A; Pletnikova A; Bagga R; Vita A; N Richey L; Gould N; Munshaw S; Misrilall K; Peters ME
JMIR Form Res; 2020 Jul; 4(7):e17722. PubMed ID: 32618572
[TBL] [Abstract][Full Text] [Related]
12. Reducing depressive symptomatology with a smartphone app: study protocol for a randomized, placebo-controlled trial.
Giosan C; Cobeanu O; Mogoaşe C; Szentagotai A; Mureşan V; Boian R
Trials; 2017 May; 18(1):215. PubMed ID: 28494802
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Mental Health Apps for Distress During COVID-19 in US Unemployed and Essential Workers: Remote Pragmatic Randomized Clinical Trial.
Comtois KA; Mata-Greve F; Johnson M; Pullmann MD; Mosser B; Arean P
JMIR Mhealth Uhealth; 2022 Nov; 10(11):e41689. PubMed ID: 36191176
[TBL] [Abstract][Full Text] [Related]
14. Mental Health Chatbot for Young Adults With Depressive Symptoms During the COVID-19 Pandemic: Single-Blind, Three-Arm Randomized Controlled Trial.
He Y; Yang L; Zhu X; Wu B; Zhang S; Qian C; Tian T
J Med Internet Res; 2022 Nov; 24(11):e40719. PubMed ID: 36355633
[TBL] [Abstract][Full Text] [Related]
15. MoodHacker Mobile Web App With Email for Adults to Self-Manage Mild-to-Moderate Depression: Randomized Controlled Trial.
Birney AJ; Gunn R; Russell JK; Ary DV
JMIR Mhealth Uhealth; 2016 Jan; 4(1):e8. PubMed ID: 26813737
[TBL] [Abstract][Full Text] [Related]
16. A Digital Mental Health Intervention in an Orthopedic Setting for Patients With Symptoms of Depression and/or Anxiety: Feasibility Prospective Cohort Study.
Leo AJ; Schuelke MJ; Hunt DM; Metzler JP; Miller JP; Areán PA; Armbrecht MA; Cheng AL
JMIR Form Res; 2022 Feb; 6(2):e34889. PubMed ID: 35039278
[TBL] [Abstract][Full Text] [Related]
17. Using a smartphone app to reduce cognitive vulnerability and mild depressive symptoms: Study protocol of an exploratory randomized controlled trial.
Giosan C; Mogoaşe C; Cobeanu O; Szentágotai Tătar A; Mureşan V; Boian R
Trials; 2016 Dec; 17(1):609. PubMed ID: 28031038
[TBL] [Abstract][Full Text] [Related]
18. Evaluating a Smartphone App (MeT4VeT) to Support the Mental Health of UK Armed Forces Veterans: Feasibility Randomized Controlled Trial.
Parkes S; Croak B; Brooks SK; Stevelink SAM; Leightley D; Fear NT; Rafferty L; Greenberg N
JMIR Ment Health; 2023 Aug; 10():e46508. PubMed ID: 37639295
[TBL] [Abstract][Full Text] [Related]
19. Layperson-Facilitated Internet-Delivered Cognitive Behavioral Therapy for Homebound Older Adults With Depression: Protocol for a Randomized Controlled Trial.
Kayser J; Wang X; Wu Z; Dimoji A; Xiang X
JMIR Res Protoc; 2023 Feb; 12():e44210. PubMed ID: 36811937
[TBL] [Abstract][Full Text] [Related]
20. Smartphone Cognitive Behavioral Therapy as an Adjunct to Pharmacotherapy for Refractory Depression: Randomized Controlled Trial.
Mantani A; Kato T; Furukawa TA; Horikoshi M; Imai H; Hiroe T; Chino B; Funayama T; Yonemoto N; Zhou Q; Kawanishi N
J Med Internet Res; 2017 Nov; 19(11):e373. PubMed ID: 29101095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
